PH 2 Pemigatinib in SDH-deficient GIST

Clinical trial NCT07434843 · RECRUITING

Trial details

NCT number: NCT07434843
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

SDH Gene Mutation Gastrointestinal Stromal Tumor

Start date: 2026-05-19
Primary completion: 2028-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.